IPX Company Profile and Key Details

IperionX Limited (NASDAQ:IPX) closed at $47.38 USD, gaining $2.10 (4.64%) from the previous close of $45.28. The stock is currently mid-range between its 52-week high and low $12.28 and $61.45. With a market capitalization of about $1.59 billion, IperionX Limited is classified as a small-cap and shows market-like volatility (beta ~0.97). Key stats such as the average daily volume over the past year has been around 154.45 thousand shares, in line with its 52-week average. Headquartered in Charlotte, NC, IperionX Limited operates in the Basic Materials sector and the Industrial Materials industry. Led by CEO Anastasios Arima, the company employs approximately 28 people and listed since June 21, 2022. IperionX Limited engages in the exploration and development of mineral properties.

IPX has shown mixed momentum, gaining 6.07% over the past week and -18.15% over the past quarter, though year-to-date performance is up 32.85%. Short-term trend indicators are bearishly aligned (SMA20 4.59%, SMA50 8.77%, SMA200 22.08%). The stock’s 14-day RSI is 56.58 (neutral), while the ATR of 2.57 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -22.9% below its high and over 285.99% above its low. Average 10-day trading volume of 134.43 thousand shares is below the 3-month average of 150.97 thousand, indicating normal recent market interest.

IperionX Limited generated EPS of -$1.20 over the past year. Five-year average earnings growth is -49.42%. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $74.00 to $64.00. The high target offers 56.18% upside. The low target suggests 35.08% downside. The mean target is $70.67. This offers 49.16% upside. IperionX Limited earnings surprise history is a mixed track record. The quarter that ended September 30, 2025, missed forecasts by 20.0%. The prior quarter beat by -64.71%. Over the last six quarters, Apple has recorded several small beats. These include -84.38% in September 26, 2024.

IperionX Limited has 31.58 million shares outstanding. The public float is 232.39 million shares, elevated short interest at 0.45% of float. This equals 128.19 thousand shares. The short ratio is 1.86 days. Institutional investors hold 12.48% of the float. Insiders own 0.0%.

IperionX Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.73. This means the shares are trading above this model’s fair value.

IperionX Limited trades at a P/E ratio of -39.82, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 15.23 reflecting a rich premium to book value. The P/FCF stands at -29.92, also below market averages. Compared to sector medians, IperionX Limited P/S is trading at a discount to the sector, and the P/B is far lower than peers, underscoring the brand and earnings power premium investors assign to the stock.

IperionX Limited (NASDAQ:IPX) shares are up 32.85% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows IperionX Limited trading at a premium to the broader market with a P/E of -39.82. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $52.40, suggesting 10.6% upside. Our AI forecast model points to short-term weakness (-14.77% over two weeks), a medium-term rise (138.73% over three months), and a longer-term gain (21.3% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that IperionX Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -14.77%, with price expected at $40.38 by March 11, 2026, within a range of $35.96 to $44.25 3-Month Outlook: Projected rise of 138.73%, reaching $113.11 by May 25, 2026, with a range of $110.59 to $117.73. 1-Year Outlook: Projected gain of 21.3%, with price at $57.47 by February 25, 2027, within a range of $55.05 to $59.36.